Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Julia Marie Eastland

CEO, President at Zentalis Pharmaceuticals, Inc. (ZNTL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $21K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 10SEC ZNTLZentalis Pharmaceuticals, Inc. Sell 7,86680,022 held (−9%) $2.43 $19K -12.3%
Feb 10SEC ZNTLZentalis Pharmaceuticals, Inc. Sell 88979,133 held (−1%) $2.39 $2K -10.9%